© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Why Your Chatbots Are Making Debtors More Angry
Finance
27/04/2023Why Your Chatbots Are Making Debtors More Angry

The use of automated communication tools, such as chatbots, to speak to customers has grown since the pandemic. One in four customer service companies are using AI, with 31% planning to introduce these tools in the next 18 months. The global chatbot market is

Read Full PostRead - Eye Icon
Hyundai Heavy Industries and Scania Announce Partnership
M&A
20/04/2015Hyundai Heavy Industries and Scania Announce Partnership

Scania will supply engines for next-generation large excavators and wheel loaders made by Hyundai Heavy Industries’ Construction Equipment division, under a new partnership.

Read Full PostRead - Eye Icon
4 Must-Try Innovative Contact Centre Trends
Innovation
25/04/20224 Must-Try Innovative Contact Centre Trends

Of the industries impacted by the pandemic, contact centres have had no choice but to evolve. As a result many more services are technologically driven, and numerous transactions are done online.

Read Full PostRead - Eye Icon
Why Do Judges Hand Out Multiple Life Sentences?
Legal
21/09/2022Why Do Judges Hand Out Multiple Life Sentences?

This article will discuss what this type of punishment is and how courts reach their decision to hand such sentences to law offenders. This write-up will also cite examples of people with these “back-to-back” life sentences.

Read Full PostRead - Eye Icon
The Future of Salon Management: Embracing Technology for Better Results
Innovation
03/03/2023The Future of Salon Management: Embracing Technology for Better Results

Salon management has changed drastically in the past few decades. From the adoption of modern technologies to more efficient operational systems, salons have made significant strides in improving their services.

Read Full PostRead - Eye Icon
Rocket Lawyer Boasts $223m Investment in an Innovating Legal Industry
Innovation
22/04/2022Rocket Lawyer Boasts $223m Investment in an Innovating Legal Industry

Like with many industries, customers look to the web in search of ways to spend their money as opposed to the high street. Legal services, it seems, are following the same path. Last year, Rocket Lawyer announced a $223 million investment that was led by Vista

Read Full PostRead - Eye Icon
Why Moderating Your Social Media is Important as a Business
Innovation
25/11/2022Why Moderating Your Social Media is Important as a Business

Sadly, even the most useful tool can quickly become a destructive weapon when it is placed in the wrong hands. This fact of life permeates every industry, every family, every community. Something designed to valuable and beneficial can be used to cause harm wh

Read Full PostRead - Eye Icon
Most Trusted for High-Value Transactions in the Caribbean
Strategy
29/06/2016Most Trusted for High-Value Transactions in the Caribbean

Emmanuel Jacques Almosnino is well renowned law firm, comprised of highly skilled international attorneys involved with tax, financing, real property and wealth management.

Read Full PostRead - Eye Icon
Out There: Reasons To Use Promotional Products In Your Marketing Strategy
News
03/01/2023Out There: Reasons To Use Promotional Products In Your Marketing Strategy

Promotional products are a great way for businesses to get their message out to potential customers. They are an important tool in any marketing strategy, as they can be used to build brand awareness, increase visibility and engage customers. From pens and mug



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow